Controversial use of meta-analysis for factor VIII pharmacokinetic data.
about
ReFacto and Advate: a single-dose, randomized, two-period crossover pharmacokinetics study in subjects with haemophilia A.B-domain deleted recombinant factor VIII preparations are bioequivalent to a monoclonal antibody purified plasma-derived factor VIII concentrate: a randomized, three-way crossover study.A postmarketing surveillance study of the safety and efficacy of ReFacto (St Louis-derived active substance) in patients with haemophilia A.
P2860
Controversial use of meta-analysis for factor VIII pharmacokinetic data.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Controversial use of meta-analysis for factor VIII pharmacokinetic data.
@en
Controversial use of meta-analysis for factor VIII pharmacokinetic data.
@nl
type
label
Controversial use of meta-analysis for factor VIII pharmacokinetic data.
@en
Controversial use of meta-analysis for factor VIII pharmacokinetic data.
@nl
prefLabel
Controversial use of meta-analysis for factor VIII pharmacokinetic data.
@en
Controversial use of meta-analysis for factor VIII pharmacokinetic data.
@nl
P1433
P1476
Controversial use of meta-analysis for factor VIII pharmacokinetic data.
@en
P2093
P304
746-7; author reply 748-50
P356
10.1046/J.1365-2516.2003.00835.X
P577
2003-11-01T00:00:00Z